
Melody Noel Brown
Examiner (ID: 8663, Phone: (571)272-2599 , Office: P/2917 )
| Most Active Art Unit | 2917 |
| Art Unit(s) | 2915, 2901, 2917, 2911 |
| Total Applications | 11867 |
| Issued Applications | 11761 |
| Pending Applications | 2 |
| Abandoned Applications | 102 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18161258
[patent_doc_number] => 20230027850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => BOTULINUM NEUROTOXINS FOR USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/652917
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/652917 | BOTULINUM NEUROTOXINS FOR USE IN THERAPY | Feb 27, 2022 | Abandoned |
Array
(
[id] => 17805910
[patent_doc_number] => 20220257745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS COMPRISING OF BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/679243
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679243 | COMPOSITIONS COMPRISING OF BACTERIAL STRAINS | Feb 23, 2022 | Abandoned |
Array
(
[id] => 19067185
[patent_doc_number] => 20240101611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => METHODS AND COMPOSITIONS FOR PRODUCING PROTEINS OF INTEREST IN PIGMENT DEFICIENT BACILLUS CELLS
[patent_app_type] => utility
[patent_app_number] => 18/273417
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273417
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273417 | METHODS AND COMPOSITIONS FOR PRODUCING PROTEINS OF INTEREST IN PIGMENT DEFICIENT BACILLUS CELLS | Feb 21, 2022 | Pending |
Array
(
[id] => 17852222
[patent_doc_number] => 20220282264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Endotoxin-free Production of Recombinant Subunit Vaccine Components
[patent_app_type] => utility
[patent_app_number] => 17/651476
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651476 | Endotoxin-free Production of Recombinant Subunit Vaccine Components | Feb 16, 2022 | Abandoned |
Array
(
[id] => 17640682
[patent_doc_number] => 20220168420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => NOVEL ANTI-LAM AND ANTI-PIM6/LAM MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/651523
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651523 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of | Feb 16, 2022 | Issued |
Array
(
[id] => 19140476
[patent_doc_number] => 20240139264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => COMPOSITION AND KIT FOR ALLEVIATING SYMPTOMS OF RESPIRATORY ALLERGY IN TODDLERS
[patent_app_type] => utility
[patent_app_number] => 18/547277
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547277
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547277 | COMPOSITION AND KIT FOR ALLEVIATING SYMPTOMS OF RESPIRATORY ALLERGY IN TODDLERS | Feb 15, 2022 | Abandoned |
Array
(
[id] => 19111249
[patent_doc_number] => 20240122999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => Methods and Compositions Using Combinations of Lactobacillus Mucosae and Soluble Dietary Fiber
[patent_app_type] => utility
[patent_app_number] => 18/278251
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278251
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278251 | Methods and Compositions Using Combinations of Lactobacillus Mucosae and Soluble Dietary Fiber | Feb 13, 2022 | Pending |
Array
(
[id] => 19049312
[patent_doc_number] => 20240091281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INTESTINAL DAMAGE COMPRISING LEUCONOSTOC CITREUM STRAIN AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/276154
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276154
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276154 | Pharmaceutical composition for preventing or treating intestinal damage comprising | Feb 6, 2022 | Issued |
Array
(
[id] => 18955462
[patent_doc_number] => 20240043789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => THE COMPOSITION OF CULTURE MEDIA FOR FAECALIBACTERIUM PRAUSNITZII
[patent_app_type] => utility
[patent_app_number] => 17/764371
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764371 | Composition of culture media for | Feb 6, 2022 | Issued |
Array
(
[id] => 17627326
[patent_doc_number] => 20220162341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH
[patent_app_type] => utility
[patent_app_number] => 17/588760
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588760 | METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH | Jan 30, 2022 | Abandoned |
Array
(
[id] => 17805833
[patent_doc_number] => 20220257668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/586968
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586968
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586968 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Jan 27, 2022 | Abandoned |
Array
(
[id] => 17805839
[patent_doc_number] => 20220257674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/588122
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588122
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588122 | Synergistic bacterial compositions and methods of production and use thereof | Jan 27, 2022 | Issued |
Array
(
[id] => 19550182
[patent_doc_number] => 12133874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Application of breast milk-derived
[patent_app_type] => utility
[patent_app_number] => 17/578537
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 5892
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578537 | Application of breast milk-derived | Jan 18, 2022 | Issued |
Array
(
[id] => 19032563
[patent_doc_number] => 20240082378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines
[patent_app_type] => utility
[patent_app_number] => 18/261568
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261568
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261568 | Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines | Jan 13, 2022 | Pending |
Array
(
[id] => 17748191
[patent_doc_number] => 20220226394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/576339
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576339 | ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT | Jan 13, 2022 | Abandoned |
Array
(
[id] => 18986462
[patent_doc_number] => 20240058431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => NOVEL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/270947
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270947
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270947 | NOVEL COMPOSITION | Jan 4, 2022 | Pending |
Array
(
[id] => 20350060
[patent_doc_number] => 20250346912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => RECOMBINANT MICROORGANISM EXPRESSING FUCOSYLTRANSFERASE, AND METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/270293
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270293 | RECOMBINANT MICROORGANISM EXPRESSING FUCOSYLTRANSFERASE, AND METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING SAME | Dec 27, 2021 | Pending |
Array
(
[id] => 18953627
[patent_doc_number] => 20240041954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS
[patent_app_type] => utility
[patent_app_number] => 18/259014
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259014 | USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS | Dec 21, 2021 | Pending |
Array
(
[id] => 18953674
[patent_doc_number] => 20240042001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII
[patent_app_type] => utility
[patent_app_number] => 18/258842
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | Dec 20, 2021 | Pending |
Array
(
[id] => 17671029
[patent_doc_number] => 20220184196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/556294
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556294 | Methods and compositions for treating and diagnosing autoimmune diseases | Dec 19, 2021 | Issued |